The Trump administration has bought up the world's supply of COVID-19 drug remdesivir


A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
Health and Human Services Secretary Alex Azar announced Monday an "amazing deal" reached by the Trump administration to purchase nearly all of Gilead's supply of the antiviral drug remdesivir through September. Other countries, which now won't have access to one of two proven treatments for COVID-19 for three months, did not see the deal as so amazing, at least not in the sense Azar meant.
The U.S. "got access to most of the drug supply, so there's nothing for Europe," Dr. Andrew Hill, a research fellow at Liverpool University, told The Guardian. "Imagine this was a vaccine," he added. "That would be a firestorm. But perhaps this is a taste of things to come."
Azar said the U.S. has reserved 100 percent of Gilead's remdesivir production in July and 90 percent in August and September, for a total of about 500,000 doses. "To the extent possible, we want to ensure that any American patient who needs remdesivir can get it," Azar said. Each treatment course requires an average of 6.25 vials of remdesivir at a cost of $3,200, HHS said. In other developed countries, Gilead announced, a course of treatment will cost nearly $1,000 less, or $2,340.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The U.S. has the world's worst confirmed COVID-19 outbreak by far — 2.6 million of the world's 10.5 million confirmed cases, 127,000 of 512,000 confirmed deaths — and the disease is not under control. But "the U.S. has taken an 'America first' attitude throughout the global pandemic," The Guardian says, trying to negotiate exclusive rights to a German vaccine and briefly securing first dibs on another vaccine from French pharmaceutical firm Sanofi — before Germany and France, respectively, stepped in.
Remdesivir, developed to fight Ebola (unsuccessfully), has been shown to reduce hospital stays for COVID-19 patients with severe cases. The only other treatment found to be effective is the steroid dexamethasone, which reduced the number of deaths by up to a third in a British study. "There has been no attempt to buy up the world's stocks of dexamethasone because there is no need," The Guardian notes: "The drug is 60 years old, cheap, and easily available everywhere."
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Peter Weber is a senior editor at TheWeek.com, and has handled the editorial night shift since the website launched in 2008. A graduate of Northwestern University, Peter has worked at Facts on File and The New York Times Magazine. He speaks Spanish and Italian and plays bass and rhythm cello in an Austin rock band. Follow him on Twitter.
-
6 vibrant homes with art studios
Feature Featuring a six-bedroom home in Vermont and a rustic-modern house in California
By The Week Staff Published
-
Experts are worried about tuberculosis again
Speed Read The deadly disease regained its crown as the world's biggest infectious killer in October 2022
By Devika Rao Published
-
The daily gossip: Beyoncé is bringing the 'Renaissance' tour to movie theaters, Taylor Swift attends another Chiefs game with famous pals, and more
Feature The daily gossip: October 2, 2023
By Brendan Morrow Published
-
Elon Musk used Starlink, which saved Ukraine, to thwart a Ukrainian attack on Russia's Crimea fleet
Speed Read
By Peter Weber Published
-
Fitch downgrades US credit rating, citing 'repeated debt-limit political standoffs'
Speed Read
By Peter Weber Published
-
Bed Bath & Beyond relaunches online following bankruptcy
Speed Read
By Justin Klawans Published
-
San Francisco's iconic Anchor Brewing is closing after 127 years
Speed Read
By Peter Weber Published
-
Lawmakers say tax prep companies illegally shared taxpayer data with Meta and Google
Speed Read
By Theara Coleman Published
-
Microsoft wins FTC battle to acquire Activision Blizzard
Speed Read
By Theara Coleman Published
-
Tesla reports record quarter for sales
Speed Read
By Catherine Garcia Published
-
48 states sue telecom company over billions of robocalls
Speed Read
By Theara Coleman Published